|
Case studies for ALS/MND disorders |
Á¦ 1 ºÎ |
ÁÂÀå : ±Ç±âÇÑ(ÇѸ²ÀÇ´ë ½Å°æ°ú) |
09:00~09:40 |
Case study for ALS/MND I |
¼¹üõ(¼º±Õ°üÀÇ´ë ½Å°æ°ú) / ³ëÇÐÀç(¼øõÇâÀÇ´ë ½Å°æ°ú) |
|
09:40~10:20 |
Case study for ALS/MND II |
ÀÓ¿µ¹Î(¿ï»êÀÇ´ë ½Å°æ°ú) / ¹Ú°æ¼®(¼¿ïÀÇ´ë ½Å°æ°ú) |
|
10:20~10:40 |
Coffee break |
Á¦ 2 ºÎ |
ÁÂÀå : À̵¿±¹(´ë±¸°¡Å縯ÀÇ´ë ½Å°æ°ú) |
10:40~11:20 |
Case study for ALS/MND III |
³²Å½Â(Àü³²ÀÇ´ë ½Å°æ°ú) / ±èÁ¾±¹ (µ¿¾ÆÀÇ´ë ½Å°æ°ú) |
|
11:20~12:00 |
Case study for ALS/MND IV |
¹Ú¹Î¼ö(¿µ³²ÀÇ´ë ½Å°æ°ú) / ±èº´ÁØ (¼º±Õ°üÀÇ´ë ½Å°æ°ú) |
|
12:00~13:20 |
Á¡½É½Ä»ç |
Á¦ 3 ºÎ |
ÁÂÀ壺±è½ÂÇö(ÇѾçÀÇ´ë) |
13:20~13:45 |
Clinical diagnosis of ALS / MND |
¹èÁ¾¼®(ÀÎÁ¦ÀÇ´ë ½Å°æ°ú) |
|
13:45~14:10 |
Electrophysiological diagnosis of ALS / MND |
¾È¼®¿ø(Áß¾ÓÀÇ´ë ½Å°æ°ú) |
|
14:10~14:35 |
Management of ALS / MND |
Á¶Áß¾ç(ÀÎÁ¦ÀÇ´ë ½Å°æ°ú) |
|
14:35~14:50 |
Coffee break |
Basic science of ALS / MND |
Á¦ 4 ºÎ |
ÁÂÀ壺±è½Â¹Î(¿¬¼¼ÀÇ´ë ½Å°æ°ú) |
14:50~15:15 |
Genetic diagnosis of ALS / MND |
±ââ¼®(¼º±Õ°üÀÇ´ë Áø´Ü°Ë»çÀÇÇаú) |
|
15:15~15:40 |
Pathogenesis of ALS / MND |
¼ºÁ¤ÁØ(¼¿ïÀÇ´ë ½Å°æ°ú) |
|
15:40~16:05 |
Clinical therapeutic trials in ALS / MND |
¹é¿ø±â(ÇѾçÀÇ´ë ½Å°æ°ú) |
|
[Satellite symposium] The Korea ALS/MND registry and epidemiologic study of ALS |
16:10~16:20 |
The Korea ALS/MND registry & epidemiologic study |
¼ÕÀºÈñ(Ãæ³²ÀÇ´ë ½Å°æ°ú) |
|
16:20~16:40 |
Preliminary result of epidemiologic study |
°´ë¿ë(¿¬¼¼´ë º¸°Ç´ëÇпø) |
|
16:40~17:00 |
Scoring of ALS-FRS |
¹é¿ø±â(ÇѾçÀÇ´ë ½Å°æ°ú) |
|
17:00~17:20 |
Electrophysiological recording of fasciculation: Awaji criteria |
¼ÕÀºÈñ(Ãæ³²ÀÇ´ë ½Å°æ°ú) |
|
|